112. Baseline demographics and evaluation of health utility in movement disorder patients receiving onabotulinumtoxinA (BOTOX) treatment in a prospective observational cohort study: MOBILITY. (January 2015) - Jog, Mandar; Bhogal, Meetu; Trentin, Grace